LivaNova (LIVN) Enterprise Value Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.39% |
| Dec 31, 2025 | -21.18% |
| Jun 30, 2025 | -19.10% |
| Mar 31, 2025 | -26.13% |
| Dec 31, 2024 | -10.88% |
| Sep 30, 2024 | -7.99% |
| Jun 30, 2024 | 8.85% |
| Mar 31, 2024 | -11.72% |
| Dec 31, 2023 | -6.17% |
| Sep 30, 2023 | -9.46% |
| Jun 30, 2023 | 1.37% |
| Mar 31, 2023 | -39.24% |
| Dec 31, 2022 | -80.10% |
| Sep 30, 2022 | -54.16% |
| Jun 30, 2022 | -99.26% |
| Mar 31, 2022 | -93.52% |
| Dec 31, 2021 | -88.19% |
| Sep 30, 2021 | -51.46% |
| Jun 30, 2021 | -109.36% |
| Mar 31, 2021 | -57.24% |
| Dec 31, 2020 | -39.64% |
| Sep 30, 2020 | -51.78% |
| Jun 30, 2020 | -75.95% |
| Mar 31, 2020 | -26.12% |
| Dec 31, 2019 | -15.39% |
| Sep 30, 2019 | -5.78% |
| Jun 30, 2019 | 14.37% |
| Mar 31, 2019 | 18.69% |
| Dec 31, 2018 | 26.65% |